Onconova chooses Specialised Therapeutics to market rigosertib in Australia and New Zealand
Executive Summary
Specialised Therapeutics Asia Pte. Ltd. licensed exclusive rights to commercialize rigosertib in Australia and New Zealand for Onconova Therapeutics Inc.
Deal Industry
- Biotechnology
- Pharmaceuticals
-
Pharmaceuticals
- Specialty Pharmaceuticals
Deal Status
- Final
Deal Type
-
Alliance
- Includes Contract
- Includes Royalty or Profit Split Information
- Marketing (Licensing)
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice